Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Skorecki

Showing results (131-140 of 134) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 134 results.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 17, 2023
Genetic Markers Among the Israeli Druze Minority Population With End-Stage Kidney DiseaseOmer Shlomovitz, Danit Atias-Varon, Dina Yagel, et al.
Frontiers in Medicine|September 13, 2021
HIV Viremia Is Associated With <i>APOL1</i> Variants and Reduced JC-ViruriaEtty Kruzel-Davila, Barbara Mensah Sankofi, Ernestine Kubi Amos-Abanyie, et al.
Clinical Kidney Journal|February 10, 2025
Multiethnic prevalence of the <i>APOL1</i> G1 and G2 variants among the Israeli dialysis populationDror Ben-Ruby, Danit Atias-Varon, Maayan Kagan, et al.
Nature Medicine|June 27, 2017
A tripartite complex of suPAR, APOL1 risk variants and α<sub>v</sub>β<sub>3</sub> integrin on podocytes mediates chronic kidney diseaseSalim S Hayek, Kwi Hye Koh, Morgan E Grams, et al.
Pageof 14

Showing results (131-140 of 134) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 17, 2023
Genetic Markers Among the Israeli Druze Minority Population With End-Stage Kidney DiseaseOmer Shlomovitz, Danit Atias-Varon, Dina Yagel, et al.
Frontiers in Medicine|September 13, 2021
HIV Viremia Is Associated With <i>APOL1</i> Variants and Reduced JC-ViruriaEtty Kruzel-Davila, Barbara Mensah Sankofi, Ernestine Kubi Amos-Abanyie, et al.
Clinical Kidney Journal|February 10, 2025
Multiethnic prevalence of the <i>APOL1</i> G1 and G2 variants among the Israeli dialysis populationDror Ben-Ruby, Danit Atias-Varon, Maayan Kagan, et al.
Nature Medicine|June 27, 2017
A tripartite complex of suPAR, APOL1 risk variants and α<sub>v</sub>β<sub>3</sub> integrin on podocytes mediates chronic kidney diseaseSalim S Hayek, Kwi Hye Koh, Morgan E Grams, et al.
Pageof 14